Navigation Links
Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
Date:10/21/2010

h to deliver effective and new HIV medicines as well as support communities affected by HIV. For more information on the company, its management, portfolio, pipeline and commitment, please visit www.viivhealthcare.com.

About Shionogi & Co., Ltd.Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi's Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain, and Metabolic Syndrome. The Company is the originator of innovative medicines which have been successfully delivered to millions of patients worldwide. In addition, Shionogi is engaged in new research areas such as allergy and cancer. Contributing to the health of patients around the world through development in these therapeutic areas is Shionogi's primary goal. For more details, please visit www.shionogi.co.jp. For more information on Shionogi Inc. headquartered in Florham Park, NJ, please visit www.shionogi-inc.com. Inquiries:UK Media inquiries:

Rebecca Hunt

Claire Brough

(020) 8380 6275

(020) 8047 5502US Media inquiries:

Marc Meachem

(919) 483 5005GSK European Analyst/Investor inquiries:

David Mawdsley

(020) 8047 5564Sally Ferguson

(020) 8047 5543Gary Davies

(020) 8047 5503GSK US Analyst/ Investor inquiries:

Tom Curry

(215) 751 5419Jen Hill Baxter

(215) 751 7002Shionogi & Co., Ltd. Enquiries

Corporate Communications

+81 6 6209 7885Cautionary statement regarding forward-looking statementsGlaxoSmithKline disclosure notice: Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, inc
'/>"/>

SOURCE Shionogi-ViiV Healthcare LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. HealthSport Enters Letter of Intent With CURE Pharmaceutical for Joint Development of Unique Pediatric Malaria Drug Product and Other Healthcare Related Products
2. McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico
3. Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevadas Future
4. Janam Introduces Mobile Healthcare Product Line
5. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
6. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
7. Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference
8. Healthcare Providers Gain Control of Demand Channels With GHX Procurement Suite; 12 Percent Supply Spend Savings Achievable
9. ADVENTRX to Participate in Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
10. Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya
11. Aging of America: Demographics of Demand and Profits in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... VEGAS , March 26, 2015 Zimmer ... Vivacit-E ® Advanced Bearing Technology with ... A paper published earlier this month reported that, ... Vivacit-E Advanced Bearing Technology featuring Vitamin E ... maintained a significant wear rate reduction of 95 percent, ...
(Date:3/26/2015)... 26 mars 2015 Finesse Solutions annonce ... pour les innovateurs, visionnaires et cadres de direction ... d,une durée de deux jours proposée exclusivement sur ... le centre ville de San Francisco ... Il s,agira d,un forum destiné aux leaders des ...
(Date:3/26/2015)... Utah , March 26, 2015  Flexpoint Sensor ... with new customers it has received and shipped during ... get a lot of interest in the sensors for ... these sensors or have had custom sensors built for ... LLC who received custom sensors for medical rehab; a ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Finesse Solutions annonce l'événement Cellworld 2015 2Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2
... and Non-Whites New to Antiretroviral Therapy Respond ... Similarly to ... treatment,regimens containing once-daily or twice-daily dosing of Abbott,s (NYSE:,ABT) protease ... (reducing the amount of HIV-1),and improving the immune system (increasing ...
... Tolerx, Inc., a,biopharmaceutical company engaged in the ... of immune-mediated diseases, announced today,that Genentech, a collaborator, ... anti-CD4 monoclonal antibody, into a phase 1 clinical ... is evaluating the,safety and tolerability of both single ...
Cached Medicine Technology:Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 2Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 4Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 6Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 7Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 8Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... the Way, Brightening the Day, on Friday, May 1, ... Morristown, NJ. , Guests will enjoy an elegant ... delightful cuisine, an extensive silent auction and heart-warming testimony ... awards will be presented to this year’s honorees. ...
(Date:3/26/2015)... San Frencisco, CA (PRWEB) March 26, 2015 ... Implant Center are proud to announce expanded offerings for ... The San Francisco Dental Implant Center has long been ... efforts have expanded its offerings to meet the strong ... pride in our reputation as a top-rated dental implant ...
(Date:3/26/2015)... 2015 Innovative research and additional ... preventing often fatal ruptures, says The Bee Foundation, ... awareness of brain aneurysms and funding innovative research ... national attention with the death of longtime ... last Friday after suffering a ruptured brain aneurysm. ...
(Date:3/26/2015)... March 26, 2015 The National ... Assessment and Evaluation , has announced its partnership ... institutions, organizations, and corporations to accurately and securely ... learning. , Utilizing Questionmark’s state-of-the-art software and ... will offer improved delivery of the seventy-five to ...
(Date:3/26/2015)... Volunteers will collectively walk hundreds of miles ... funds to support the American Parkinson Disease Association’s ... the Cure. The Optimism Walk campaign is ... than 20 locations including, Boston, Chicago, Connecticut, Madison, Nashville, ... Seattle, St. Louis, New York, Nevada, South Florida, Vermont, ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2
... ... ... Wellness Center is now offering Kennedy Spinal Decompression Therapy to Springfield area residents suffering ... for lower back and neck pain sufferers., , ,Spinal Decompression Therapy has been clinically ...
... ... payroll processing time thus freeing staff to spend more time serving patients and less time ... ... improvement in staff productivity and payroll processing time thus freeing staff to spend more time ...
... ) today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to ... ... , , ... ...
... The Autism Consortium, an innovative research, clinical and family ... for families with autism spectrum disorders (ASDs), announced today ... testing methods for autism spectrum disorders is available from ... in their eFirst pages today and will appear in ...
... kind to date using cardiac computed tomography angiography, people ... artery disease are at higher risk of developing obstructive ... Ford Hospital researchers say. Researchers analyzed the data ... tomography angiography and found that those with a family ...
... ACL, meniscus at same time is one advance, ,Tommy John, ... Repairing a torn knee meniscus at the same time as ... children, a new study finds. , Meniscus cartilage acts as ... one of four major ligaments in the knee. , This ...
Cached Medicine News:Health News:Chiropractor Springfield, VA - Dr. Todd P. Sullivan Announces The Addition of Spinal Decompression Therapy 2Health News:Hospice of Baton Rouge Selects CellTrak as a Good Steward of Time and Talent 2Health News:Hospice of Baton Rouge Selects CellTrak as a Good Steward of Time and Talent 3Health News:Hospice of Baton Rouge Selects CellTrak as a Good Steward of Time and Talent 4Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 2Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 3Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 4Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 5Health News:Autism Consortium study in Pediatrics shows CMA finds more genetic abnormalities than current tests 2Health News:Autism Consortium study in Pediatrics shows CMA finds more genetic abnormalities than current tests 3Health News:Autism Consortium study in Pediatrics shows CMA finds more genetic abnormalities than current tests 4Health News:Family history is strong predictor of obstructive coronary artery disease using CCTA 2Health News:Strides Seen in Orthopedic Surgery for Kids 2
... 1 (IGF-1) is a polypeptide of 70 amino ... number of related insulin-like growth factors present in ... homology with proinsulin and has a number of ... growth hormone (GH) dependent to a high degree, ...
...
...
...
Medicine Products: